| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 268.00M | 262.20M | 254.20M | 297.20M | 255.30M |
| Gross Profit | 55.80M | 49.00M | 48.90M | 70.50M | 57.50M |
| EBITDA | 7.80M | 13.30M | 30.40M | 17.80M | 17.70M |
| Net Income | -4.90M | -4.90M | -3.70M | -13.60M | 2.30M |
Balance Sheet | |||||
| Total Assets | 440.00M | 476.30M | 499.70M | 571.80M | 593.50M |
| Cash, Cash Equivalents and Short-Term Investments | 66.30M | 139.10M | 48.90M | 50.60M | 65.80M |
| Total Debt | 22.40M | 26.90M | 33.20M | 30.90M | 32.50M |
| Total Liabilities | 110.50M | 128.60M | 136.40M | 154.10M | 156.20M |
| Stockholders Equity | 291.60M | 308.50M | 325.80M | 365.00M | 388.60M |
Cash Flow | |||||
| Free Cash Flow | -4.50M | -12.10M | -26.50M | -20.30M | -22.70M |
| Operating Cash Flow | 7.40M | -2.60M | -14.90M | -5.90M | -12.00M |
| Investing Cash Flow | -15.20M | 58.00M | 10.00M | -3.20M | -4.00M |
| Financing Cash Flow | -21.80M | -9.00M | -5.90M | -12.10M | -18.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | £762.29M | 4.21 | 15.66% | 4.89% | 21.29% | 32.15% | |
83 Outperform | £932.25M | 3.43 | 19.40% | 3.24% | 1.98% | 24.57% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | £142.19M | -26.80 | -1.73% | 5.22% | 2.21% | -0.51% | |
50 Neutral | £5.11M | 55.56 | -30.89% | ― | -6.07% | 50.59% | |
41 Neutral | £444.99K | -0.12 | ― | ― | ― | ― |